NMRA

Neumora Therapeutics Inc

• Reuters·1d ago

  Neumora Therapeutics to join Needham Virtual Healthcare Conference fireside chat

• TipRanks·1d ago

  H.C. Wainwright Sticks to Its Buy Rating for Neumora Therapeutics, Inc. (NMRA)

• TipRanks·3d ago

  Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

• TipRanks·5d ago

  Neumora Therapeutics management to meet with Piper Sandler

• Seeking Alpha·6d ago

  FuboTV and Yext are the most oversold among U.S. small-cap stocks

• TipRanks·04/01 05:00

  Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA) and Sandoz Group Ltd (OtherSDZXF)

• TipRanks·04/01 00:10

  Neumora Therapeutics Maps High-Stakes Catalyst Road Ahead

• TipRanks·03/31 14:50

  Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)

• Dow Jones·03/31 13:24

  Neumora Therapeutics Price Target Maintained With a $14.00/Share by Guggenheim

• Benzinga·03/31 13:15

  Guggenheim Reiterates Buy on Neumora Therapeutics, Maintains $14 Price Target

• TipRanks·03/31 11:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Neumora Therapeutics, Inc. (NMRA) and Aurinia Pharmaceuticals (AUPH)

• TipRanks·03/31 11:02

  Neumora Therapeutics, Inc. (NMRA) Gets a Buy from Guggenheim

• Dow Jones·03/31 10:43

  Neumora Therapeutics Price Target Maintained With a $8.00/Share by Needham

• Benzinga·03/31 10:33

  Needham Reiterates Buy on Neumora Therapeutics, Maintains $8 Price Target

• TipRanks·03/31 06:01

  Neumora Therapeutics Warns Nasdaq Delisting Risk Could Hit Liquidity, Share Price, and Capital Access